共 71 条
- [1] Ritchlin CT(2017)Psoriatic arthritis N Engl J Med 376 957-970
- [2] Colbert RA(2019)Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? J Rheumatol 46 1428-1430
- [3] Gladman DD(2019)Assessing disease activity in psoriatic arthritis: a literature review Rheumatol Ther 6 23-32
- [4] Lubrano E(2010)Defining disease activity in psoriatic arthritis: a proposed objective target for treatment Ann Rheum Dis 69 48-53
- [5] Scriffignano S(2016)Defining low disease activity states in psoriatic arthritis using novel composite disease instruments J Rheumatol 43 371-375
- [6] Perrotta FM(2020)Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study Semin Arthritis Rheum 4 709-718
- [7] Tucker LJ(2017)Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: a cross-sectional analysis of a longitudinal cohort J Rheumatol 44 1159-1164
- [8] Coates LC(2021)The burden of psoriatic arthritis in the biological era: data from the Belgian Epidemiological Psoriatic Arthritis Study (BEPAS) Rheumatology (Oxford) 6 1012-1019
- [9] Helliwell PS(2020)Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices RMD Open 73 1441-1447
- [10] Coates LC(2014)A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative Ann Rheum Dis 69 2665-2673